Salt and crystalline form thereof of a corticotropin releasing factor receptor antagonist
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 26, 2006
Issued Date -
N/A
app pub date -
Nov 10, 2004
filing date -
Nov 25, 2003
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides 4-(bis(2-methoxyethyl)amino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-[1-,5-a]-pyrazolo-1,3,5-triazine benzenesulfonate salt and a crystalline polymorph thereof. Further provided are pharmaceutical compositions containing the salt and methods of treating CRF-related disorders using said salt.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully